Mia's Feed
Medical News & Research

Open Science Drives Development of Broad-Spectrum Coronavirus Antiviral

Open Science Drives Development of Broad-Spectrum Coronavirus Antiviral

Share this article

A new broad-spectrum coronavirus antiviral, ASAP-0017445, developed through global open science and AI collaboration, shows promising potential as a next-generation treatment. Source: Medical Xpress.

2 min read

A groundbreaking antiviral drug candidate, named ASAP-0017445, has been identified as a promising broad-spectrum treatment targeting coronaviruses. This candidate was recently nominated as a pre-clinical drug by the Drugs for Neglected Diseases initiative (DNDi). Notably, this antiviral is the first developed through a global crowdsourced effort combined with open science principles, utilizing artificial intelligence (AI) tools from the COVID Moonshot initiative, which originated at Diamond Light Source.

ASAP-0017445 is a main protease inhibitor, showing effective activity against SARS-CoV-2 and other related viruses such as MERS-CoV. Its design and development involved international collaboration and open sharing of data, enabling the rapid advancement of this potential therapeutic. The open-science approach allowed researchers worldwide to access extensive structural data and contribute molecules for testing, fostering a transparent and accelerated drug discovery process.

The COVID Moonshot project, launched in March 2020, exemplifies the power of global collaboration. It received over 18,000 molecule submissions aimed at inhibiting the main protease of SARS-CoV-2, with all structural data and compounds made publicly accessible for further research. This open data initiative has been crucial in optimizing compounds like ASAP-0017445, which holds potential as an affordable and effective antiviral medicine accessible globally.

The structure of ASAP-0017445 was disclosed in March 2025, and all associated data are publicly available, enabling other scientists to build upon this work. This case highlights how advanced research infrastructure, collaborative efforts, and the integration of AI can significantly speed up the development of antiviral drugs, especially in response to emerging health threats.

The effort underscores the importance of transparency and open collaboration in accelerating drug discovery, with the ultimate goal of providing accessible treatments for future coronavirus outbreaks. Source: Medical Xpress

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

The Role of Cellular Antennas in Regulating Fat Cell Development and Obesity Prevention

New research highlights the vital role of primary cilia in fat tissue development and obesity prevention through signaling pathway regulation.

Patients Choosing Extended 10-Year Hormone Therapy for Breast Cancer

A recent study reveals that nearly half of women with early-stage breast cancer are opting for extended 10-year hormone therapy to reduce recurrence risk, especially among higher-risk groups. The decision is influenced by doctor recommendations and personal concerns about cancer recurrence, highlighting the importance of shared decision-making in personalized cancer treatment.

New Survey Highlights the Need for Better Public Awareness on SIDS Prevention

A new survey underscores the urgent need for public education on safe sleep practices and the risks of secondhand smoke to prevent SIDS and save infant lives.

Understanding Heat-Related Illnesses: Red Flags and Protective Measures During Extreme Temperatures

Learn about the red flags and safety measures for heat-related illnesses during extreme temperatures. Expert insights on protecting vulnerable populations and understanding the health impacts of heatwaves.